Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials

Similar Items

• Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
  od: Jung, Da Hyun, i dr.
  Izdano: (2021)
• Notice of Retraction: Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials
  Izdano: (2014)
• Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
  od: Liu, Junyuan, i dr.
  Izdano: (2020)
• Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis
  od: Nishizawa, Toshihiro, i dr.
  Izdano: (2015)
• Endoscopic Submucosal Dissection in the Era of Proton Pump Inhibitors
  od: Isomoto, Hajime, i dr.
  Izdano: (2009)